On the basis of these prior findings, we conducted the present study to investigate whether ox‐HDL affected PCOS and the underlying mechanism involved in the regulatory mechanism of p65/miR‐34a and FOS in PCOS rat model and GCs treated with ox‐HDL. The gene discussed is FOS; the disease is polycystic ovary syndrome.